These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4315010)

  • 1. Carbohydrate changes in liver disease.
    Sherlock S
    Am J Clin Nutr; 1970 Apr; 23(4):462-6. PubMed ID: 4315010
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbohydrate homeostasis, liver and diabetes.
    Felig P; Sherwin R
    Prog Liver Dis; 1976; 5():149-71. PubMed ID: 775538
    [No Abstract]   [Full Text] [Related]  

  • 3. [Coexistence of liver glycogenosis, Fanconi's syndrome and abnormal galactose metabolism in a 3-year-old child].
    Klinowska W; Iwańczak F; Jagodzińska M
    Pol Tyg Lek; 1980 Dec; 35(52):2065-6. PubMed ID: 6945566
    [No Abstract]   [Full Text] [Related]  

  • 4. [Principles of physiopathlogy: hypoglycemia].
    Bonnal J
    Rev Med Liege; 1974 Apr; 29(8):217-21. PubMed ID: 4596925
    [No Abstract]   [Full Text] [Related]  

  • 5. [Disorders of carbohydrate metabolism in diseases of the liver on the basis of intravenous glucose and fructose administration in patients with hepatitis and liver cirrhosis].
    Meythaler F
    Landarzt; 1964 Aug; 40(23):971-6. PubMed ID: 5827937
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism.
    Farrell GC; Cooksley WG; Hart P; Powell LW
    Gastroenterology; 1978 Oct; 75(4):580-8. PubMed ID: 710827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deranged metabolism of cyclic nucleotides in liver diseases.
    Matsushima T; Maekubo H; Yoshida T; Taneda H; Yoshida J; Miyazaki T; Okada F
    Horm Metab Res; 1985 Jun; 17(6):306-7. PubMed ID: 2991101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood clearance rate as an adjunct to the 198 Au hepatoscan.
    Bahk YW
    Br J Radiol; 1972 Jan; 45(529):24-30. PubMed ID: 4332734
    [No Abstract]   [Full Text] [Related]  

  • 9. [Glycoregulation and liver diseases].
    Guillon J; Charbonnel B; Le Bodic L; Chupin M; Ozanne P; Veyrac MJ
    Journ Annu Diabetol Hotel Dieu; 1980 May; ():181-95. PubMed ID: 6995669
    [No Abstract]   [Full Text] [Related]  

  • 10. [Transferrin anomalies in some acute and chronic liver diseases].
    Fiaschi E; Scuro LA; Dobrilla G
    Epatologia; 1969; 15(4):279-94. PubMed ID: 5407546
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha-fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not induce AFP synthesis.
    Alpert E; Feller ER
    Gastroenterology; 1978 May; 74(5 Pt 1):856-8. PubMed ID: 76587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver biopsy: conventional histologic techniques.
    Chejfec G
    Lab Res Methods Biol Med; 1983; 7():491-507, C9-12. PubMed ID: 6312230
    [No Abstract]   [Full Text] [Related]  

  • 13. Dynamic metabolic change is indicative of inflammation-induced transformation of hepatic cells.
    Peng B; Liu F; Han R; Luo G; Cathopoulis T; Lu K; Li X; Yang L; Liu GY; Cai JC; Shi SL
    Int J Biochem Cell Biol; 2015 Sep; 66():45-58. PubMed ID: 26205150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The feedback control of hepatic cholesterol synthesis in Ugandan patients with liver disease.
    Bissell DM; Alpert E
    Cancer Res; 1972 Jan; 32(1):149-52. PubMed ID: 4332471
    [No Abstract]   [Full Text] [Related]  

  • 15. Human alpha 1-microglobulin in various hepatic disorders.
    Itoh Y; Enomoto H; Takagi K; Kawai T; Yamanaka T
    Digestion; 1983; 27(2):75-80. PubMed ID: 6195036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics in the study of liver pathology.
    Parent R; Beretta L
    J Hepatol; 2005 Jul; 43(1):177-83. PubMed ID: 15894398
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma.
    Shen J; Huang CK; Yu H; Shen B; Zhang Y; Liang Y; Li Z; Feng X; Zhao J; Duan L; Cai X
    J Cell Mol Med; 2017 May; 21(5):986-992. PubMed ID: 28224705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glycogenosis with cirrhosis in 2 brothers. Significance of the demonstrated enzyme defects].
    Gentil C; Odievre M; Vassoyan J; Alagille D
    Arch Fr Pediatr; 1972 Jan; 29(1):79-97. PubMed ID: 4504126
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac involvement in inherited disorders of metabolism.
    Blieden LC; Moller JH
    Prog Cardiovasc Dis; 1974; 16(6):615-31. PubMed ID: 4207425
    [No Abstract]   [Full Text] [Related]  

  • 20. Carbohydrate metabolism in hepatocellular carcinoma: where does the glucose go?
    Marchesini G; Bianchi G
    Hepatology; 1989 Aug; 10(2):253-5. PubMed ID: 2545591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.